Your browser doesn't support javascript.
loading
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Wulf, Gerald G; Altmann, Bettina; Ziepert, Marita; D'Amore, Francesco; Held, Gerhard; Greil, Richard; Tournilhac, Olivier; Relander, Thomas; Viardot, Andreas; Wilhelm, Martin; Wilhelm, Christian; Pezzutto, Antonio; Zijlstra, Josee M; Neste, Eric Van Den; Lugtenburg, Pieternella J; Doorduijn, Jeanette K; Gelder, Michel van; van Imhoff, Gustaaf W; Zettl, Florian; Braulke, Friederike; Nickelsen, Maike; Glass, Bertram; Rosenwald, Andreas; Gaulard, Philippe; Loeffler, Markus; Pfreundschuh, Michael; Schmitz, Norbert; Trümper, Lorenz.
Afiliação
  • Wulf GG; Hematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany. gerald.wulf@med.uni-goettingen.de.
  • Altmann B; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
  • Ziepert M; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
  • D'Amore F; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Held G; Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany.
  • Greil R; Department of internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Cancer Research Institute, Salzburg, Austria.
  • Tournilhac O; Laboratory for Immunological and Molecular Cancer Research (SCI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria.
  • Relander T; Service de therapie cellullaire et Hematologie Clinique adulte, CHU Estaing, Clermont-Ferrand, France.
  • Viardot A; Department of Clinical Sciences Lund, Lund University Hospital, Lund, Sweden.
  • Wilhelm M; Department Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Wilhelm C; Paracelsus Medical University, Medizinische Klinik 5, Klinikum Nuernberg, Nuernberg, Germany.
  • Pezzutto A; Department of Hematology, University Hospital Marburg, Marburg, Germany.
  • Zijlstra JM; Medizinische Klinik mit Schwerpunkt Hämatologie/Onkologie Campus Virchow-Klinikum, Charite, Berlin, Germany.
  • Neste EVD; Department of Hematology, Vrije Universiteit Medisch Centrum Amsterdam, Amsterdam, The Netherlands.
  • Lugtenburg PJ; Cliniques universitaires UCL Saint-Luc, Brussels, Belgium.
  • Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Gelder MV; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Imhoff GW; Department of Hematology, Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands.
  • Zettl F; Department of Hematology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Braulke F; Klinikum Traunstein, Department Hematology and Oncology, Traunstein, Germany.
  • Nickelsen M; Hematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany.
  • Glass B; Onkologie Lerchenfeld, Hamburg, Germany.
  • Rosenwald A; HELIOS Klinikum Berlin-Buch, Berlin, Germany.
  • Gaulard P; Institute of Pathology, University of Wuerzburg and Comprehensive Cancer Centre (CCC) Mainfranken, Wuerzburg, Germany.
  • Loeffler M; Department of Pathology, Hospital Henri Mondor, APHP, Inserm U955, Université Paris-Est, Créteil, France.
  • Pfreundschuh M; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
  • Schmitz N; Department of Hematology and Oncology, University Hospital Saarland, Homburg, Germany.
  • Trümper L; Department of Hematology, Oncology, Haemostaseology, and Pneumology, University Hospital, Muenster, Germany.
Leukemia ; 35(1): 143-155, 2021 01.
Article em En | MEDLINE | ID: mdl-32382083

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido